Bottom line
What is BHCFX's expense ratio?
BHCFX's expense ratio is 1.1%, or about $110 a year on every $10,000 invested. That is more expensive than 63% of health care sector funds we track (median 0.96%). Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Apr 30, 2026
BHCFX fee table
| Net expense ratio | 1.1% |
|---|---|
| Gross expense ratio | 1.27% |
| Management fee | 0.75% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.27% |
| Fee waiver / reimbursement | -0.17% |
Source: Fund prospectus fee table, filed Apr 30, 2026
What BHCFX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| BHCFX | $112 | $350 | $606 | $1,340 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.1% expense ratio costs roughly $60,400 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).
Cheaper alternatives to BHCFX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
| Fund | Expense ratio | Saves per year | Saves over 20 yrs* | Overlap |
|---|---|---|---|---|
| PRHSX T. Rowe Price | 0.83% | $27 | $1,373 | 50% |
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.